Rates of Progression in Diabetic Retinopathy During Different Time Periods
暂无分享,去创建一个
R. Klein | P. Mitchell | T. Wong | M. Larsen | H. Flynn | A. Pleil | B. Wirostko | M. Mwamburi | Gayatri Ranganathan | M. Hernandez-Medina | G. Ranganathan | T. Wong | T. Wong | T. Wong | R. Klein | T. Wong
[1] R. Klein,et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials , 2008, The Lancet.
[2] H. Parving,et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial , 2008, The Lancet.
[3] Xiao-Hua Zhou,et al. Statistical Methods for Meta‐Analysis , 2008 .
[4] F. Ferris,et al. Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. , 2008, Investigative ophthalmology & visual science.
[5] H. Parving,et al. DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. , 2008 .
[6] T. Wong,et al. Management of diabetic retinopathy: a systematic review. , 2007, JAMA.
[7] Helen K. Li,et al. Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial. , 2007, Archives of ophthalmology.
[8] Toke Bek,et al. The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. , 2006, Acta ophthalmologica Scandinavica.
[9] A. Flyvbjerg,et al. Prevention and early detection of vascular complications of diabetes , 2006, BMJ : British Medical Journal.
[10] J. Ludvigsson,et al. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes—the Linköping Diabetes Complications Study , 2004, Diabetologia.
[11] Stephen J. Aldington,et al. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study , 1995, Diabetologia.
[12] N. Congdon,et al. Important causes of visual impairment in the world today. , 2003, JAMA.
[13] Stephen W. Sorensen,et al. Lifetime risk for diabetes mellitus in the United States. , 2003, JAMA.
[14] B. Zinman,et al. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. , 2003, Diabetes care.
[15] N. Tajima,et al. Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] H. Parving,et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. , 2003, Diabetes care.
[17] Francisco Gómez-Ulla,et al. Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy. , 2002, Diabetes care.
[18] Marilyn James,et al. Cost effectiveness analysis of screening for sight threatening diabetic eye disease , 2000, BMJ : British Medical Journal.
[19] S. Vitale. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: what can we learn at 14 years? , 1998, Ophthalmology.
[20] R. Klein,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. , 1998, Ophthalmology.
[21] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[22] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[23] H. Parving,et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study , 1997, BMJ.
[24] T. Batchelder,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. , 1995, Archives of ophthalmology.
[25] J Ludvigsson,et al. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.
[26] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[27] F. Ferris,et al. How effective are treatments for diabetic retinopathy? , 1993, JAMA.
[28] Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.
[29] D L DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. , 1989, Ophthalmology.
[30] D L DeMets,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. , 1989, Archives of ophthalmology.
[31] F. Ferris,et al. Photocoagulation for diabetic macular edema. , 1987, Archives of ophthalmology.
[32] D L DeMets,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. , 1987, Ophthalmology.
[33] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[34] Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. , 1985, Archives of ophthalmology.
[35] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .
[36] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.